Literature DB >> 21606375

ES cell-derived renewable and functional midbrain dopaminergic progenitors.

Sangmi Chung1, Jung-Il Moon, Amanda Leung, Daniel Aldrich, Stefan Lukianov, Yui Kitayama, Sara Park, Yan Li, Vadim Y Bolshakov, Thomas Lamonerie, Kwang-Soo Kim.   

Abstract

During early development, midbrain dopaminergic (mDA) neuronal progenitors (NPs) arise from the ventral mesencephalic area by the combined actions of secreted factors and their downstream transcription factors. These mDA NPs proliferate, migrate to their final destinations, and develop into mature mDA neurons in the substantia nigra and the ventral tegmental area. Here, we show that such authentic mDA NPs can be efficiently isolated from differentiated ES cells (ESCs) using a FACS method combining two markers, Otx2 and Corin. Purified Otx2(+)Corin(+) cells coexpressed other mDA NP markers, including FoxA2, Lmx1b, and Glast. Using optimized culture conditions, these mDA NPs continuously proliferated up to 4 wk with almost 1,000-fold expansion without significant changes in their phenotype. Furthermore, upon differentiation, Otx2(+)Corin(+) cells efficiently generated mDA neurons, as evidenced by coexpression of mDA neuronal markers (e.g., TH, Pitx3, Nurr1, and Lmx1b) and physiological functions (e.g., efficient DA secretion and uptake). Notably, these mDA NPs differentiated into a relatively homogenous DA population with few serotonergic neurons. When transplanted into PD model animals, aphakia mice, and 6-OHDA-lesioned rats, mDA NPs differentiated into mDA neurons in vivo and generated well-integrated DA grafts, resulting in significant improvement in motor dysfunctions without tumor formation. Furthermore, grafted Otx2(+)Corin(+) cells exhibited significant migratory function in the host striatum, reaching >3.3 mm length in the entire striatum. We propose that functional and expandable mDA NPs can be efficiently isolated by this unique strategy and will serve as useful tools in regenerative medicine, bioassay, and drug screening.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606375      PMCID: PMC3111266          DOI: 10.1073/pnas.1016443108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.

Authors:  A Chellaiah; W Yuan; M Chellaiah; D M Ornitz
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

Authors:  S H Lee; N Lumelsky; L Studer; J M Auerbach; R D McKay
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

3.  Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Authors:  Sangmi Chung; Kai-C Sonntag; Therese Andersson; Lars M Bjorklund; Jae-Joon Park; Dong-Wook Kim; Un Jung Kang; Ole Isacson; Kwang-Soo Kim
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

4.  Directed differentiation of embryonic stem cells into motor neurons.

Authors:  Hynek Wichterle; Ivo Lieberam; Jeffery A Porter; Thomas M Jessell
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

5.  Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.

Authors:  Gonçalo Castelo-Branco; Joseph Wagner; Francisco J Rodriguez; Julianna Kele; Kyle Sousa; Nina Rawal; Hilda Amalia Pasolli; Elaine Fuchs; Jan Kitajewski; Ernest Arenas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

6.  FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate.

Authors:  W Ye; K Shimamura; J L Rubenstein; M A Hynes; A Rosenthal
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

7.  Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c.

Authors:  Shigeki Ohmachi; Tadahisa Mikami; Morichika Konishi; Ayumi Miyake; Nobuyuki Itoh
Journal:  J Neurosci Res       Date:  2003-05-15       Impact factor: 4.164

8.  Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon.

Authors:  V Tropepe; M Sibilia; B G Ciruna; J Rossant; E F Wagner; D van der Kooy
Journal:  Dev Biol       Date:  1999-04-01       Impact factor: 3.582

9.  Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

Authors:  Jong-Hoon Kim; Jonathan M Auerbach; José A Rodríguez-Gómez; Iván Velasco; Denise Gavin; Nadya Lumelsky; Sang-Hun Lee; John Nguyen; Rosario Sánchez-Pernaute; Krys Bankiewicz; Ron McKay
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

10.  A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro.

Authors:  H Sasaki; C Hui; M Nakafuku; H Kondoh
Journal:  Development       Date:  1997-04       Impact factor: 6.868

View more
  45 in total

Review 1.  Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons.

Authors:  Aaron B Bradford; Patrick M McNutt
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

Review 2.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

3.  Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.

Authors:  Julio Cesar Aguila; Alexandra Blak; Joris van Arensbergen; Amaia Sousa; Nerea Vázquez; Ariane Aduriz; Mayela Gayosso; Maria Paz Lopez Mato; Rakel Lopez de Maturana; Eva Hedlund; Kai-Christian Sonntag; Rosario Sanchez-Pernaute
Journal:  Stem Cells Transl Med       Date:  2014-07-14       Impact factor: 6.940

4.  Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo.

Authors:  Xinjiang Kang; Huadong Xu; Sasa Teng; Xiaoyu Zhang; Zijun Deng; Li Zhou; Panli Zuo; Bing Liu; Bin Liu; Qihui Wu; Li Wang; Meiqin Hu; Haiqiang Dou; Wei Liu; Feipeng Zhu; Qing Li; Shu Guo; Jingli Gu; Qian Lei; Jing Lü; Yu Mu; Mu Jin; Shirong Wang; Wei Jiang; Kun Liu; Changhe Wang; Wenlin Li; Kang Zhang; Zhuan Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

Review 5.  The quest of cell surface markers for stem cell therapy.

Authors:  Anna Meyfour; Sara Pahlavan; Mehdi Mirzaei; Jeroen Krijgsveld; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Cell Mol Life Sci       Date:  2020-07-24       Impact factor: 9.261

Review 6.  Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).

Authors:  Haneul Noh; Zhicheng Shao; Joseph T Coyle; Sangmi Chung
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-28       Impact factor: 5.187

7.  Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models.

Authors:  Ali Fathi; Mehdi Mirzaei; Banafsheh Dolatyar; Mehdi Sharifitabar; Mahnaz Bayat; Ebrahim Shahbazi; Jaesuk Lee; Mohammad Javan; Su-Chun Zhang; Vivek Gupta; Bonghee Lee; Paul A Haynes; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Mol Cell Proteomics       Date:  2018-05-29       Impact factor: 5.911

8.  Tracing synaptic connectivity onto embryonic stem cell-derived neurons.

Authors:  Isabella Garcia; Longwen Huang; Kevin Ung; Benjamin R Arenkiel
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

9.  Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment.

Authors:  Xiaobo Wei; Huimin Gao; Jing Zou; Xu Liu; Dan Chen; Jinchi Liao; Yunqi Xu; Long Ma; Beisha Tang; Zhuohua Zhang; Xiang Cai; Kunling Jin; Ying Xia; Qing Wang
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

Review 10.  Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.

Authors:  Zhiguo Chen
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.